Cardiovascular manifestations of monogenic periodic fever syndromes

[1]  M. Casula,et al.  Colchicine for cardiovascular medicine: a systematic review and meta-analysis. , 2022, Future cardiology.

[2]  P. Little,et al.  Mouse models of atherosclerosis in translational research. , 2022, Trends in pharmacological sciences.

[3]  Bisher Sawaf,et al.  Association of familial Mediterranean fever and epicardial adipose tissue: A systematic review and meta‐analysis , 2022, Health science reports.

[4]  D. Foell,et al.  The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, an , 2022, Annals of the Rheumatic Diseases.

[5]  S. Ozen,et al.  Familial Mediterranean Fever: How to Interpret Genetic Results? How to Treat? A Quarter of a Century After the Association with the Mefv Gene , 2022, Current Rheumatology Reports.

[6]  H. Marzouk,et al.  Cardiac repolarization abnormalities in children with familial Mediterranean fever , 2022, Pediatric Rheumatology.

[7]  D. Monos,et al.  Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles , 2021, Annals of the Rheumatic Diseases.

[8]  J. Kuemmerle-Deschner,et al.  Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today? , 2021, Journal of clinical medicine.

[9]  A. Shabbir,et al.  Cardiovascular Sequelae and Genetics of Familial Mediterranean Fever: A Literature Review , 2021, Pulse.

[10]  E. Tatar,et al.  The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors , 2020, International Urology and Nephrology.

[11]  C. Rotimi,et al.  Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis , 2020, Nature Immunology.

[12]  T. Whayne.  Inflammation May be the Future of Cardiovascular Risk Reduction: Does Colchicine have a Current Indication? , 2020, American Journal of Cardiovascular Drugs.

[13]  E. Pras,et al.  Familial Mediterranean fever is associated with increased risk for ischaemic heart disease and mortality–Perspective derived from a large database , 2020, International journal of clinical practice.

[14]  Mark M. Davis,et al.  Emergent high fatality lung disease in systemic juvenile arthritis , 2019, medRxiv.

[15]  D. Hoyer,et al.  Association Between Systemic Inflammation, Carotid Arteriosclerosis, and Autonomic Dysfunction , 2019, Translational Stroke Research.

[16]  A. Kup,et al.  Colchicine’s Effects on Electrocardiographic Parameters in Newly Diagnosed Familial Mediterranean Fever Patients , 2019, Zeitschrift für Rheumatologie.

[17]  M. Sormani,et al.  Classification criteria for autoinflammatory recurrent fevers , 2019, Annals of the rheumatic diseases.

[18]  D. Saadoun,et al.  Association of Vasculitis and Familial Mediterranean Fever , 2019, Front. Immunol..

[19]  H. E. Sönmez,et al.  The clinical spectrum of Henoch–Schönlein purpura in children: a single-center study , 2019, Clinical Rheumatology.

[20]  H. Ede,et al.  The relation of novel cardiovascular risk parameters in patients with familial Mediterranean fever , 2019, JRSM cardiovascular disease.

[21]  Jiang-hong Deng,et al.  Gene mutations and clinical phenotypes in 15 Chinese children with cryopyrin-associated periodic syndrome (CAPS) , 2017, Science China Life Sciences.

[22]  L. Eckardt,et al.  Colchicine Increases Ventricular Vulnerability in an Experimental Whole‐Heart Model , 2017, Basic & clinical pharmacology & toxicology.

[23]  Ş. Arslan,et al.  The Relationship Between Atherogenic Index and Carotid Artery Atherosclerosis in Familial Mediterranean Fever , 2017, Angiology.

[24]  H. Pieringer,et al.  Cardiovascular disease in patients with autoinflammatory syndromes , 2017, Rheumatology International.

[25]  E. Erken,et al.  Cardiac disease in familial Mediterranean fever , 2017, Rheumatology International.

[26]  S. Özen,et al.  Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants , 2017, Clinical Rheumatology.

[27]  A. Tanoğlu,et al.  Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima–media thickness and endothelium-dependent vasodilation , 2017, Clinical Rheumatology.

[28]  Jian-ming Wang,et al.  Association of KCTD10, MVK, and MMAB polymorphisms with dyslipidemia and coronary heart disease in Han Chinese population , 2016, Lipids in Health and Disease.

[29]  S. Emre,et al.  Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever , 2015, Pediatric Rheumatology.

[30]  Kayoko Sato,et al.  Sudden cardiac arrest secondary to cardiac amyloidosis in a young woman with cryopyrin-associated periodic syndrome , 2015, BMJ Case Reports.

[31]  S. Ozen,et al.  The myths we believed in familial Mediterranean fever: what have we learned in the past years? , 2015, Seminars in Immunopathology.

[32]  M. Duru,et al.  Relation of fragmented QRS to tissue Doppler-derived parametersin patients with familial Mediterranean fever , 2013, Wiener klinische Wochenschrift.

[33]  D. Karabel,et al.  Assessment of epicardial adipose tissue thickness and the mean platelet volume in children with familial Mediterranean fever , 2015, Italian Journal of Pediatrics.

[34]  M. Keskin,et al.  Assessment of left ventricular functions with tissue Doppler, strain, and strain rate echocardiography in patients with familial Mediterranean fever , 2014, Anatolian journal of cardiology.

[35]  P. Keskinoğlu,et al.  Cardiac autonomic functions in children with familial Mediterranean fever , 2016, Clinical Rheumatology.

[36]  J. Carrero,et al.  Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events. , 2014, Rheumatology.

[37]  H. Takada,et al.  Early progression of atherosclerosis in children with chronic infantile neurological cutaneous and articular syndrome. , 2014, Rheumatology.

[38]  A. Örnek,et al.  P Wave Dispersion and QT Dispersion in Adult Turkish Migrants with Familial Mediterranean Fever Living in Germany , 2014, International journal of medical sciences.

[39]  N. Wulffraat,et al.  Periodic Fever in MVK Deficiency: A Patient Initially Diagnosed With Incomplete Kawasaki Disease , 2014, Pediatrics.

[40]  R. Hegazy,et al.  MEFV gene mutations and cardiac phenotype in children with familial Mediterranean fever: a cohort study , 2014, Pediatric Rheumatology.

[41]  G. Ozkececi,et al.  Atherogenic index as a predictor of atherosclerosis in subjects with familial Mediterranean fever. , 2014, Medicina.

[42]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[43]  M. Boes,et al.  Mevalonate kinase deficiency, a metabolic autoinflammatory disease. , 2013, Clinical immunology.

[44]  Alexander F. Wilson,et al.  Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease , 2013, Proceedings of the National Academy of Sciences.

[45]  I. Ben-Zvi,et al.  Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF) , 2012, Clinical Rheumatology.

[46]  A. Oto,et al.  Evaluation of various cardiac autonomic indices in patients with familial Mediterranean fever on colchicine treatment , 2012, Autonomic Neuroscience.

[47]  G. Paolazzi,et al.  Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study , 2012, Clinical Research in Cardiology.

[48]  U. Nussinovitch,et al.  QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients , 2012, Clinical Rheumatology.

[49]  U. Nussinovitch,et al.  Abnormal heart rate variability in AA amyloidosis of familial mediterranean fever , 2011, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[50]  G. Kitas,et al.  Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors , 2011, Rheumatology International.

[51]  M. Galeazzi,et al.  Autoinflammatory diseases and cardiovascular manifestations , 2011, Annals of medicine.

[52]  A. Bakkaloğlu,et al.  Decrease in the rate of secondary amyloidosis in Turkish children with FMF: are we doing better? , 2010, European Journal of Pediatrics.

[53]  L. Mouthon,et al.  Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. , 2010, Arthritis and rheumatism.

[54]  M. Kaya,et al.  Assessment of heart rate recovery index in patients with familial Mediterranean fever , 2010, Rheumatology International.

[55]  C. Baldari,et al.  Idiopathic Recurrent Pericarditis Refractory to Colchicine Treatment Can Reveal Tumor Necrosis Factor Receptor-Associated Periodic Syndrome , 2009, International journal of immunopathology and pharmacology.

[56]  G. Cayla,et al.  Acute myocarditis and Tumor Necrosis Factor Receptor-Associated Periodic (TRAP) syndrome: first case described and discussion. , 2009, European journal of internal medicine.

[57]  U. Nussinovitch,et al.  Heart rate variability in familial Mediterranean fever , 2009, Rheumatology International.

[58]  A. Bakkaloğlu,et al.  Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis , 2008, Rheumatology International.

[59]  R. Collins,et al.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.

[60]  M. Herold,et al.  Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment , 2007, Annals of the rheumatic diseases.

[61]  B. Oran,et al.  The evaluation of carotid intima-media thickness in children with familial Mediterranean fever , 2008, Clinical Rheumatology.

[62]  H. Gullu,et al.  Impaired coronary microvascular function in familial Mediterranean fever. , 2007, Atherosclerosis.

[63]  S. Akar,et al.  Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever , 2007, Clinical Rheumatology.

[64]  A. Oto,et al.  Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. , 2006, Journal of the American College of Cardiology.

[65]  J. Piette,et al.  Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease. , 2005, Arthritis and rheumatism.

[66]  A. Bakkaloğlu,et al.  Familial Mediterranean Fever (FMF) in Turkey: Results of a Nationwide Multicenter Study , 2005, Medicine.

[67]  A. Evans,et al.  Polymorphism R92Q of the tumour necrosis factor receptor 1 gene is associated with myocardial infarction and carotid intima-media thickness – The ECTIM, AXA, EVA and GENIC Studies , 2004, European Journal of Human Genetics.

[68]  D. Yeshurun,et al.  Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever , 2004, Rheumatology International.

[69]  M. Eki̇m,et al.  Job strain and high work demands and lack of opportunity to control work are related to increased risk of coronorary heart disease in British government employees , 2003, Heart.

[70]  D. Kastner,et al.  The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. , 2001, American journal of human genetics.

[71]  D. Zemer,et al.  Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). , 1997, QJM : monthly journal of the Association of Physicians.